Literature DB >> 15957734

Activated protein C for the treatment of fulminant meningococcal septicaemia.

G L Thomas1, T Wigmore, P Clark.   

Abstract

We report two cases of meningococcal septic shock with multiple organ failure treated with prompt administration of activated protein C. This was associated with a rapid clinical improvement and early cessation of organ support. Both patients survived to hospital discharge with no long-term sequelae.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15957734     DOI： 10.1177/0310057X0403200224

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN： 0310-057X            Impact factor:   1.669


  2 in total

1.  Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.

Authors:  Gareth L Thomas; Peter Clark
Journal:  Intensive Care Med       Date:  2005-11-10       Impact factor: 17.440

2.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.